Trial Profile
A study evaluating safety and efficacy of Perampanel in patients with intellectual disability and epilepsy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Nov 2020
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 04 Sep 2017 New trial record